AHA Scientific Sessions 2023: Abstracts from Yale Cardiovascular Medicine

Scientific Sessions 2023 Programming

November 10, 2023

QCORS.03. QCOR at Scientific Sessions: Early Career Investigator Award Session
102AB
Deep Learning-Based Natural Language Processing of Discharge Summaries for Automated Identification of Heart Failure With Reduced Ejection Fraction
Arash Aghajani Nargesi, Brigham and Women’s Hosp, Boston, MA; Philip Adejumo, Yale Sch of Med; Benjamin Rosand, Yale Sch of Med, New York, NY; Lovedeep Singh Dhingra, Yale Sch Of Med, New Haven, CT; Astrid Hengartner, Yale Sch of Med; Sounok Sen, Yale New Haven Hosp, New Haven, CT; Tariq Ahmad, Yale Medical Ctr, Guilford, CT; Faraz S Ahmad, Northwestern Univ Sch Med, Chicago, IL; Harlan M Krumholz, Yale Univ, New Haven, CT; Rohan Khera, Yale Sch of Med, New Haven, CT


November 11, 2023

GR.MDP4. Traditional and Non-traditional Risk Factors for CVD: Women and Sex Differences
Moderated Digital Posters 5
MDP153 – Unheard Voices: The Burden of Ischemia and No Obstructive Coronary Artery Disease in Women
Marah Maayah, Nazar Chowdhury, Kristie Walenczyk, Carolyn M Mazure, Matthew Burg, Erica S Spatz, Michelle Bernabeo, Jessica Ritchie, Samit Shah, Yale Univ Sch of Med, New Haven, CT

IM.CVS.313. Leveraging Cardiac Imaging Biomarkers in Cardio-Oncology
118AB
Advanced Imaging in Cancer Cardiotoxicities: New Insights
Lauren A Baldassarre, New Haven, CT

VA.CVS.368. Mind and Vascular: The Case for Integrating Behavioral Health into Vascular Disease Management
103B
Carlos Mena-Hurtado, New Haven, CT and Kim G Smolderen, New Haven, CT

CM.APS.P2. Obesity, Adiposity, and CVD: New Insights Regarding a Growing Challenge
Zone 3, Science and Technology Hall
Sa3010 / 3010 – Unraveling the Interplay Between Age, Obesity, and Mortality Across Adulthood: Insights From National Health and Nutrition Examination Survey 1999-2018
Yuan Lu, Yunhan Mou, Yale Univ, New Haven, CT; Yuntian Liu, Yale Sch of Med, New Haven, CT; Jeph Herrin, FBA, Charlottesville, VA; Harlan M Krumholz, Yale Univ, New Haven, CT

Sa3010 / 3010 – Unraveling the Interplay Between Age, Obesity, and Mortality Across Adulthood: Insights From National Health and Nutrition Examination Survey 1999-2018
Yuan Lu, Yunhan Mou, Yale Univ, New Haven, CT; Yuntian Liu, Yale Sch of Med, New Haven, CT; Jeph Herrin, FBA, Charlottesville, VA; Harlan M Krumholz, Yale Univ, New Haven, CT

EA.APS.P2. Clinical EP Diagnosis: ECG Wearables, Patches, & Loops
Zone 2, Science and Technology Hall
Sa2054 / 2054 – Accuracy of Apple Watch for Detection of Atrial Fibrillation: A Systematic Review and Meta-Analysis
Farah Yasmin, Yale Univ Sch of Med, New Haven, CT; Abdul Moeed, Dow Medical Coll, Karachi, Sindh, Pakistan; Mariam Adil, Dow Medical Coll, Karachi, Pakistan; Saad Ur Rahman, Carle Fndn Hosp, Urbana, IL; F. Perry Wilson, Yale Univ Sch of Med, New Haven, CT

GR.APS.P1. Ischemic Heart Disease in Women, with or without CAD
Zone 3, Science and Technology Hall
Sa3132 / 3132 – Coronary Angiography Alone Compared With Invasive Coronary Function Testing in Women With Ischemia and No Obstructive Coronary Artery Disease
Natasha Cigarroa, Yale New Haven Hosp, New Haven, CT; Marah Jawad Fayez Maayah, New Haven, CT; Arshjot Khokhar, Yale New Haven Hosp, CT; Steffne Kunnirickal, Yale New Haven Hosp; Alexandra Schwann, Nida Latif, Yale New Haven Hosp, CT; Natalija Odanovic, Kaitlin Maciejewski, Yale New Haven Hosp, New Haven, CT; Steven Pfau, Yale Univ, New Haven, CT; Samit Shah, Yale Sch of Med, New Haven, CT

Sa3132 / 3132 – Coronary Angiography Alone Compared With Invasive Coronary Function Testing in Women With Ischemia and No Obstructive Coronary Artery Disease
Natasha Cigarroa, Yale New Haven Hosp, New Haven, CT; Marah Jawad Fayez Maayah, New Haven, CT; Arshjot Khokhar, Yale New Haven Hosp, CT; Steffne Kunnirickal, Yale New Haven Hosp; Alexandra Schwann, Nida Latif, Yale New Haven Hosp, CT; Natalija Odanovic, Kaitlin Maciejewski, Yale New Haven Hosp, New Haven, CT; Steven Pfau, Yale Univ, New Haven, CT; Samit Shah, Yale Sch of Med, New Haven, CT

HF.APS.P12. Novemberel Therapies For Heart Failure Across the Spectrum of Ejection Fraction
Zone 2, Science and Technology Hall
Sa2179 / 2179 – The Effect of Torsemide vs Furosemide Across the Renal Function Spectrum – Insights From the TRANSFORM-HF Trial
Pieter Martens, Cleveland, OH; Stephen J Greene, Durham, NC; Robert J Mentz, Duke Clinical Res Inst, Durham, NC; Shuang Li, Duke Clinical Res Inst, Durham, NC, Durham, NC; Daniel Wojdyla, Duke Clinical Res Inst, Durham, NC; Eric Eisenstein, Duke Clinical Res Inst, Durham, NC, Durham, NC; Kevin Anstrom, Univ of North Carolina, Chapel Hill, NC; Bertram Pitt, Univ of Michigan Sch, Ann Arbor, MI; Eric J Velazquez, Yale Univ Sch of Med, New Haven, CT; Wai Hong Wilson Tang, Yale Univ Sch of Med, New Haven, CT, Gates Mills, OH

HY.APS.P2. Outcomes and Mechanisms of Treatment Approaches for Hypertension
Zone 4, Science and Technology Hall
Sa4128 / 4128 – Utilization and Spending on Fixed-Dose Combination Treatment for Hypertension in Medicare and Medicaid, 2016-2020
Mohammed Essa, Harvard Sch of Public Health, Watertown, MA; Joseph S Ross, Yale Univ Sch Med, New Haven, CT; Sanket Dhruva, UCSF Sch of Med, San Francisco, CA; Nihar R Desai, Yale Sch of Med, New Haven, CT; Erica S Spatz, Yale Univ Sch Med, New Haven, CT; Kamil Faridi, Yale Sch of Med, New Haven, CT

IM.APS.P4. Novemberel Technologies for an Increasingly Common Imaging Modality
Zone 2, Science and Technology Hall
Sa2343 / 2343 – Novel Cardiac Dynamics Modeling of Clinical Cardiac MRIs Can Identify Who Has Clonal Hematopoiesis of Indeterminate Potential With High Accuracy
Emanuele Zappala, James Cross, Anthos Christofides, Carlos Matute Martinez, Ritujith Jayakrishnan, Yunju Im, Ana Ferrigno Guajardo, Yale, New Haven, CT; Shawn Ahn, New Haven, CT; Alokkumar Jha, Weill Cornell Med, New York, NY; Stephanie Halene, Jennifer VanOudenhove, Yale, New Haven, CT; David Van Dijk, Yale Univ, New Haven, CT; Jennifer M Kwan, Yale, New Haven, CT

QU.APS.P10. Beyond Traditional Models: In Novemberations in Cardiovascular Risk Prediction and Precision Medicine
Zone 3, Science and Technology Hall
Sa3250 / 3250 – Overestimation of Major Amputation Risk in Patients Undergoing Peripheral Vascular Intervention for Peripheral Artery Disease When Not Accounting for Mortality Risk
Gaelle Romain, Kim G Smolderen, Jacob Cleman, Carlos Mena-Hurtado, Yale Univ, New Haven, CT

Sa4288 / 4288 – Late Complications After Interrupted Aortic Arch Repair
John F Keaney III, Yale Sch of Med, New Haven, CT; Jeremy Asnes, New Haven, CT; Roland Assi, Yale Univ, New Haven, CT; Tony Pastor, Yale Sch of Med, Hamden, CT

VA.APS.P1. Therapeutic Interventions for Improving Life and Limb Outcomes in PAD Patients
Zone 4, Science and Technology Hall
Sa4320 / 4320 – Comparative Analysis of Mortality and Amputation Rates in Patients Undergoing Atherectomy for Infra-Popliteal Peripheral Arterial Disease: Insight From the VQI
Yasser Jamil, Yale Univ, New Haven, CT; Michael Nanna, Yale Univ Sch of Med, New Haven, CT; Cassius I Ochoa, Yale Sch of Med, New Haven, CT; Carlos Mena-Hurtado, Robert Ramak Attaran, Yale Univ, New Haven, CT

Sa4328 / 4328 – Five-Year Major Amputation Risk in Patients Undergoing Lower Extremity Bypass Taking into Account All-Cause Mortality Risk and Age Groups
Gaelle Romain, Jacob Cleman, Carlos Mena-Hurtado, Kim G Smolderen, Yale Univ, New Haven, CT

CS.ME.496. Eliminating Health Inequity in Cardiovascular Disease
Main Event II
Keith B Churchwell, New Haven, CT

VA.AOS.350. Quest Diagnostics and Steve Rusckowski Early Career Investigator Award for Preventive Cardiovascular Medicine Research
103B
359 – Development and Multinational Validation of a Machine Learning-Based Optimization for Efficient Screening for Elevated Lipoprotein(a)
Arya Aminorroaya, Yale Sch of Med, New Haven, CT; Lovedeep Singh Dhingra, Yale Sch Of Med, New Haven, CT; Seyedmohammad Saadatagah, Baylor Coll of Med, Houston, TX; Erica S Spatz, Yale Univ Sch of Med, New Haven, CT; Evangelos K Oikonomou, Yale Univ Sch of Med, New Haven, CT, New Haven, CT; Rohan Khera, Yale Univ Sch of Med, New Haven, CT

HF.RFO29. Uncovering the Mysteries of Heart Failure Diagnosis and Evaluation
Zone 2, Science and Technology Hall
527 – Detection of Left Ventricular Systolic Dysfunction From PDF Outputs of ECGs Obtained on Wearable Devices
Veer Sangha, Yale Universty, New Haven, CT; Akshay Khunte, Yale Univ, New Haven, CT; Lovedeep Singh Dhingra, Yale Sch Of Med, New Haven, CT; Evangelos K Oikonomou, Yale Sch Of Med, New Haven, CT, New Haven, CT; Rohan Khera, Yale Sch of Med, New Haven, CT

CO.APS.P3. Lifestyle and Cardiovascular Health: Nutrition, Sleep, and Physical Activity
Zone 4, Science and Technology Hall
Sa4088 / 4088 – Clonal Hematopoiesis of Indeterminate Potential (CHIP) is an Independent Risk Factor for Cardiomyopathy in Patients With Solid Malignancy
Carlos F Matute Martinez, Ritujith Jayakrishnan, Ana Ferrigno Guajardo, Etienne Leveille, Derrick Lin, Yunju Im, Anthos Christofides, Yale Sch of Med, New Haven, CT; Nathan Chen, Lauren A Baldassarre, Jennifer VanOudenhove, Yale Univ, New Haven, CT; Stephanie Halene, John Hwa, Jennifer M Kwan, Yale Sch of Med, New Haven, CT

P.APS.P11. In-Hospital and Post-Acute Event Cardiovascular Outcomes I
Zone 3, Science and Technology Hall
Sa3058 / 3058 – Impact of the Pandemic on AMI Hospitalizations and Outcomes: A Comprehensive Medicare Fee-for-Service Analysis
Mitsuaki Sawano, Xin Xin, Yale Univ, New Haven, CT; Yuan Lu, Yuan Lu, Jersey City, NJ; Cesar Caraballo, Rohan Khera, Yale Sch of Med, New Haven, CT; Karthik Murugiah, Fairfield, CT; Zhenqiu Lin, Yale Univ, Cheshire, CT; Harlan M Krumholz, Yale Univ, New Haven, CT

EP.APS.P14. Health Equity and Structural Racism: Focus on Cardiovascular Outcomes and Care
Zone 3, Science and Technology Hall
Sa3089 / 3089 – Racial Differences Among Patients Undergoing Nuclear Myocardial Perfusion Imaging
Catherine X Wright, Erica S Spatz, Edward J Miller, Attila Feher, Yale Sch of Med, New Haven, CT

EP.APS.P17. Socioeconomic Disparities and Cardiovascular Health
Zone 3, Science and Technology Hall
Sa3115 / 3115 – Access to Pacemaker Implantation Amongst Medicare Beneficiaries: Travel Distance and Time to Nearest Clinician
Pegah Khaloo, Yale Sch of Med, New Haven, CT; Kevin Wheelock, New Haven, CT; Sohum Kapadia, Yale Univ, New Haven, CT; Rohan Khera, Yale Sch of Med, New Haven, CT

HF.APS.P4. Leading Clinical Research in Cardiomyopathies
Zone 2, Science and Technology Hall
Sa2256 / 2256 – Detection of Hypertrophic Cardiomyopathy From Noisy Single-Lead Electrocardiography
Akshay Khunte, Yale Univ, New Haven, CT; Arya Aminorroaya, Yale Sch of Med, New Haven, CT; Lovedeep Singh Dhingra, Yale Sch Of Med, New Haven, CT; Veer Sangha, Yale Universty, New Haven, CT; Evangelos K Oikonomou, Yale Univ, New Haven, CT; Sounok Sen, Yale Sch of Med, New Haven, CT; Harlan M Krumholz, Yale Univ, New Haven, CT; Christopher M Kramer, Univ. of Virginia Health System, Charlottesville, VA; Milind Y Desai, Univ. of Virginia Health System, Charlottesville, VA, Solon, OH; Rohan Khera, Yale Sch of Med, New Haven, CT

Sa2256 / 2256 – Detection of Hypertrophic Cardiomyopathy From Noisy Single-Lead Electrocardiography
Akshay Khunte, Yale Univ, New Haven, CT; Arya Aminorroaya, Yale Sch of Med, New Haven, CT; Lovedeep Singh Dhingra, Yale Sch Of Med, New Haven, CT; Veer Sangha, Yale Universty, New Haven, CT; Evangelos K Oikonomou, Yale Univ, New Haven, CT; Sounok Sen, Yale Sch of Med, New Haven, CT; Harlan M Krumholz, Yale Univ, New Haven, CT; Christopher M Kramer, Univ. of Virginia Health System, Charlottesville, VA; Milind Y Desai, Univ. of Virginia Health System, Charlottesville, VA, Solon, OH; Rohan Khera, Yale Sch of Med, New Haven, CT

CH.AOS.358. Young Hearts Early Career Investigator Competition
108A
114 – Presenilin 1 Deletion in Smooth Muscle Cells Ameliorates Hypermuscularization and Stenosis in Elastin Aortopathy
Junichi Saito, Jui M Dave, Freddy Duarte Lau, Daniel M Greif, Yale Cardiovascular Res Ctr, New Haven, CT

EP.AOS.337. Elizabeth Barrett-Connor Research Award for Early Career Investigators in Training Competition
163 – An Explainable Machine Learning-Based Phenomapping Strategy for Adaptive Predictive Enrichment in Randomized Controlled Trials of Preventive Interventions
Evangelos K Oikonomou, Yale Sch of Med, New Haven, CT; Phyllis M Thangaraj, Yale Univ, New Haven, CT; Deepak L Bhatt, Icahn Sch of Med at Mount Sinai Health System, NY; Joseph S Ross, Lawrence H Young, Yale Univ Sch Med, New Haven, CT; Harlan M Krumholz, Yale Univ, New Haven, CT; Marc A Suchard, Yale Univ, New Haven, CT, Los Angeles, CA; Rohan Khera, Yale Sch of Med, New Haven, CT


November 12, 2023

CO.CVS.176. Oxidative Stress, Cardiovascular Injury and Cardio-Oncology: A Renaissance for Antioxidants?
204B
Carlos F Matute Martinez, New Haven, CT

HT.AOS.533. Artificial Intelligence and the Future of Cardiology
199 – ECG-GPT: Automated Complete Diagnosis Generation From ECG Images Using Novel Vision-Text Transformer Model
Akshay Khunte, Yale Univ, New Haven, CT; Veer Sangha, Yale Universty, New Haven, CT; Gregory Holste, Yale Universty, New Haven, CT, Austin, TX; Lovedeep Singh Dhingra, Arya Aminorroaya, Yale Sch of Med, New Haven, CT; Zhangyang Wang, Austin, TX; Rohan Khera, Yale Sch of Med, New Haven, CT

VA.CVS.398. Challenges in CLTI Care: Saving Limbs and Lives
103B
Carlos Mena-Hurtado, New Haven, CT

HY.MDP19. Implementation and Intervention Strategies to Improve Blood Pressure Control and Reduce Cardiovascular Disease
MDP198 – Reaching Patients With Hypertension: A Model of Remote Blood Pressure Monitoring Plus Team-Based Care
Bassel M Shanab, Leslie Y Tseng, Yale Sch of Med, New Haven, CT; Lauren Kelley, Millie Landock, Katia Astudillo, Project Access-New Haven, New Haven, CT; Carolyn Hickman, Yale New Haven Hosp, New Haven, CT; Yanting Wang, Hackensack Meridian Health, Edison, NJ; Peter Ellis, Yale Sch of Med, New Haven, CT; Katherine LaMonaca, Kathleen O’Connor Duffany, Community Alliance for Res and Engagement, New Haven, CT; Giselle Carlotta-McDonald, Yamira Ramirez, Project Access-New Haven, New Haven, CT; Alycia Santilli, Community Alliance for Res and Engagement, New Haven, CT; Erica S Spatz, Yale Univ Sch Med, New Haven, CT

Moderated Digital Posters 4
IM.RFO12. Deep Learning (a complex form of AI) Driving New and Novemberel Solutions in Risk Stratification and Rhythm Analysis
Zone 2, Science and Technology Hall
558 – An Ensemble Deep Learning Model to Automate Screening For Multiple Structural Heart Diseases on 12-Lead Electrocardiograms
Lovedeep Singh Dhingra, Yale Sch Of Med, New Haven, CT; Arya Aminorroaya, Yale Sch of Med, New Haven, CT; Akshay Khunte, Yale Univ, Colchester, CT; Veer Sangha, Yale Universty, New Haven, CT; Sounok Sen, Yale Universty, New Haven, CT, New Haven, CT; Norrisa Haynes, Yale Sch of Med, CT; Harlan M Krumholz, Yale Univ, New Haven, CT; Rohan Khera, Yale Sch of Med, New Haven, CT

EP.CVS.482. Diverse Population-Based Cohorts: Overview and How to Get Started
201C
BioLINCC: Leveraging existing data and opportunities for collaboration
Evangelos K Oikonomou, New Haven, CT

AC.APS.P17. Look into the Crystal Ball: Future Use of Cardiovascular Biomarkers
Zone 4, Science and Technology Hall
Su4029 / 4029 – Predictive Value of High Sensitivity Troponin T for Patients With Suspected Acute Coronary Syndromes Undergoing Invasive Coronary Angiography
Arshjot Khokhar, Alexander Ambrosini, Yale New Haven Hosp, New Haven, CT; Fangyong Li, Yale Ctr for Analytical Sciences, New Haven, CT; Rohit Sangal, Yale New Haven Hosp, New Haven, CT; Stephen Possick, Yale New Haven Hosp, Woodbridge, CT; Natasha Cigarroa, Nancy Kim, Yale New Haven Hosp, New Haven, CT; Samit Shah, Yale Sch of Med, New Haven, CT

EP.APS.P22. Neighborhood and Multilevel Social Determinants of Health in Association with Cardiovascular Health
Zone 3, Science and Technology Hall
Su3086 / 3086 – Distressed Community Index in Patients Undergoing Carotid Artery Stenting in Medicare-Linked Vascular Quality Initiative Registry
Carmen S Pajarillo, Gaelle Romain, Yale Univ, New Haven, CT; Jacob Cleman, New Haven, CT; Lindsey Scierka, Yale Univ, New Haven, CT; Scott Grubman, Yale Univ Sch of Med, New Haven, CT; Christopher Schenck, Massachusetts General Hosp, Watertown, MA; Jonathan Kluger, Kim G Smolderen, Carlos Mena-Hurtado, Yale Univ, New Haven, CT

GR.APS.P4. Aging and Care of the Older Adult
Zone 3, Science and Technology Hall
Su3143 / 3143 – Disparities in Low Cognitive Function Score and Mortality Risk Among Older Adults in the United States
Yuan Lu, Wenya Tian, Yale Univ, New Haven, CT; Xumin Li, Yale Univ, Los Angeles, CA; Yinfei Wu, Yale Univ, New Haven, CT; Yuntian Liu, Yale Sch of Med, New Haven, CT; Kai Chen, Yale Sch of Public Health, New Haven, CT; Emma Zang, Yale Univ, New Haven, CT; Jeph Herrin, FBA, Charlottesville, VA; Harlan M Krumholz, Yale Univ, New Haven, CT

IN.APS.P6 – If you Fail to Plan, You Plan to Fail: Procedural Planning in Valve interventions
Su4142 / 4142 – Driving Distances and Durations to Nearest Transcatheter Aortic Valve Replacement Center for Medicare Beneficiaries Across Continental United States
Sohum Kapadia, Yale Univ, CT; Miles Shen, Yale Sch of Med, CT; Jonathan Hanna, Yale Univ Sch of Med, New Haven, CT; Kevin Wheelock, Lovedeep Singh Dhingra, Rohan Khera, Yale Sch of Med, New Haven, CT

IM.APS.P11. Going with the Flow and Taming the Inflammation
Zone 2, Science and Technology Hall
Su2330 / 2330 – Sex Differences in the Effect of Nocturnal Hypoxia on Right Ventricular Myocardial Blood Flow
Sohum Kapadia, Yale Univ, New Haven, CT; Magdalena Malczewska, Attila Feher, Yale Univ Sch of Med, New Haven, CT; Robert deKemp II, uOttawa Heart Inst, Ottawa, ON, Canada; RAN KLEIN, uOttawa Heart Inst, Ottawa, ON, Canada, Ottawa, ON, Canada; Henry KLAR Yaggi IV, Yale Univeristy Sch of Med, New Haven, CT; Edward J Miller, Yale Univ Sch of Med, New Haven, CT; Albert J Sinusas, Yale Univ Sch Med, New Haven, CT; Stephanie Thorn, Yale Univ, New Haven, CT; Ehimen Aneni, Yale Univ Sch of Med, CT

HF.RFO29. Uncovering the Mysteries of Heart Failure Diagnosis and Evaluation
Zone 2, Science and Technology Hall
527 – Detection of Left Ventricular Systolic Dysfunction From PDF Outputs of ECGs Obtained on Wearable Devices
Veer Sangha, Yale Universty, New Haven, CT; Akshay Khunte, Yale Univ, New Haven, CT; Lovedeep Singh Dhingra, Yale Sch Of Med, New Haven, CT; Evangelos K Oikonomou, Yale Sch Of Med, New Haven, CT, New Haven, CT; Rohan Khera, Yale Sch of Med, New Haven, CT

AC.APS.P12. Treating Lipids and Diabetes in Patients with Acute Coronary Syndromes
Zone 4, Science and Technology Hall
Sa4036 / 4036 – Health Status and Long-Term Outcomes After Acute Myocardial Infarction in Patients Without Standard Modifiable Risk Factors
Nobuhiro Ikemura, Saint Luke’s Mid America Heart Inst, Kansas City, MO; Dan Nguyen, Kansas City, MO; Mitsuaki Sawano, Yale YNHH CORE, New Haven, CT; Yuan Lu, Yuan Lu, Jersey City, NJ; Kensey Gosch, Saint Luke’s Hosp, Kansas City, MO; Harlan M Krumholz, Yale Univ, New Haven, CT; John Spertus, Saint Luke’s Mid America Heart Inst, Kansas City, MO

CO.APS.P3. Lifestyle and Cardiovascular Health: Nutrition, Sleep, and Physical Activity
Zone 4, Science and Technology Hall
Sa4088 / 4088 – Clonal Hematopoiesis of Indeterminate Potential (CHIP) is an Independent Risk Factor for Cardiomyopathy in Patients With Solid Malignancy
Carlos F Matute Martinez, Ritujith Jayakrishnan, Ana Ferrigno Guajardo, Etienne Leveille, Derrick Lin, Yunju Im, Anthos Christofides, Yale Sch of Med, New Haven, CT; Nathan Chen, Lauren A Baldassarre, Jennifer VanOudenhove, Yale Univ, New Haven, CT; Stephanie Halene, John Hwa, Jennifer M Kwan, Yale Sch of Med, New Haven, CT

EP.APS.P11. In-Hospital and Post-Acute Event Cardiovascular Outcomes I
Zone 3, Science and Technology Hall
Sa3058 / 3058 – Impact of the Pandemic on AMI Hospitalizations and Outcomes: A Comprehensive Medicare Fee-for-Service Analysis
Mitsuaki Sawano, Xin Xin, Yale Univ, New Haven, CT; Yuan Lu, Yuan Lu, Jersey City, NJ; Cesar Caraballo, Rohan Khera, Yale Sch of Med, New Haven, CT; Karthik Murugiah, Fairfield, CT; Zhenqiu Lin, Yale Univ, Cheshire, CT; Harlan M Krumholz, Yale Univ, New Haven, CT

EP.APS.P14. Health Equity and Structural Racism: Focus on Cardiovascular Outcomes and Care
Zone 3, Science and Technology Hall
Sa3089 / 3089 – Racial Differences Among Patients Undergoing Nuclear Myocardial Perfusion Imaging
Catherine X Wright, Erica S Spatz, Edward J Miller, Attila Feher, Yale Sch of Med, New Haven, CT

EP.APS.P17. Socioeconomic Disparities and Cardiovascular Health
Zone 3, Science and Technology Hall
Sa3115 / 3115 – Access to Pacemaker Implantation Amongst Medicare Beneficiaries: Travel Distance and Time to Nearest Clinician
Pegah Khaloo, Yale Sch of Med, New Haven, CT; Kevin Wheelock, New Haven, CT; Sohum Kapadia, Yale Univ, New Haven, CT; Rohan Khera, Yale Sch of Med, New Haven, CT

IM.APS.P6. Echocardiographic Evaluation of Systolic and Diastolic Function: New Approaches and New Applications
Zone 2, Science and Technology Hall
Sa2364 / 2364 – Sex Differences in the Relationship Between Left Ventricular Global Longitudinal Strain and Abnormal Myocardial Flow Reserve in a Patient Population With Sleep Disordered Breathing
Magdalena Malczewska, Attila Feher, Robert L McNamara, Yale Univ, New Haven, CT; Edward J Miller, Yale Univ Sch of Med, New Haven, CT; Henry KLAR Yaggi IV, Yale Univeristy Sch of Med, New Haven, CT; Stephanie Thorn, Yale Univ, New Haven, CT; Albert J Sinusas, Yale Univ Sch Med, New Haven, CT; Ehimen Aneni, Yale Univ, New Haven, CT

IN.APS.P4. Complex Problems, Creative Solutions in PCI
Zone 4, Science and Technology Hall
Sa4164 / 4164 – Does the Number of Antianginals Influence Clinical Outcomes and Quality of Life in Stable Ischemic Heart Disease? Insights From the BARI2D Trial
Yasser Jamil, Yale Univ, New Haven, CT; Dae Yong Park, Cook County Health, Chicago, IL; Luis More Verde, Yale New Haven Hosp, New Haven, CT; Matthew W Sherwood, Behnam N Tehrani, Wayne B Batchelor, Inova Heart and Vascular Inst, Falls Church, VA; Kelly Epps-Anderson, Inova Heart and Vascular Inst, VA; Jennifer Frampton, Yale Univ, New Haven, CT; Abdulla Damluji, Inova Heart and Vascular institute, VA; Michael Nanna, Inova Heart and Vascular institute, VA, New Haven, CT


November 13, 2023

EP.ME.488. AI in the Clinic and Lab: Promise, Pitfalls, and the Data Police Main Event II
How can AI enhance a learning health system?
Rohan Khera, New Haven, CT

PH.MDP39. Variety is the Spice of Life, in the CICU
Moderated Digital Posters 4
MDP271 – Early Sedation With Dexmedetomidine in Patients With Acute Myocardial Infarction Who Require Mechanical Ventilation
Christopher S Schenck, Massachusetts General Hosp, Boston, MA; Avinainder Singh, Brigham and Women’s Hosp, Boston, MA; Soumya Banna, Sanjana Garimella, Alexander W Thomas, Yale Sch of Med, New Haven, CT; Cory Heck, Yale New Haven Hosp, New Haven, CT; Jonathan Ludmir, Massachusetts General Hosp, Boston, MA; Tariq Ali, Yale Sch of Med, New Haven, CT; David M. Dudzinski, Massachusetts General Hosp, Boston, MA; Elliott Miller, Yale Univ, New Haven, CT

QU.RFO24. Beyond the Crystal Ball: Predicting Cardiovascular Risk with Precision
Zone 3, Science and Technology Hall
600 – Health Status Profiles in Patients with New or Worsening Peripheral Artery Disease Symptoms and 12-month Hospitalization Risk from the Portrait Registry
Jacob Cleman, New Haven, CT; Gaelle Romain, Lindsey Scierka, Yale Univ, New Haven, CT; Clementine Labrosciano, Univ of Adelaide, Woodville, Australia; Mehdi H Shishehbor, Univ Hosp of Cleveland, Cleveland, OH; David M Safley, Saint Lukes Hosp, Kansas City, MO; Philip Jones, Saint Lukes Mid America Heart Inst, Kansas City, MO; John Spertus, Saint Luke’s Mid America Heart Inst, Kansas City, MO; John F Beltrame, Univ of Adelaide, Adelaide, Australia; Carlos Mena-Hurtado, Kim G Smolderen, Yale Univ, New Haven, CT

EP.APS.P29. Observational Studies in Arrhythmias
Zone 3, Science and Technology Hall
Mo3020 / 3020 – Procedural Volume and Outcomes With Atrial Fibrillation Ablation: A Report From the NCDR AFib Registry
Sharma Kattel, Univ of Minnesota/VAMC, Minneapolis, MN; Zhen Tan, Yale Univ, New Haven, CT; Zhenqiu Lin, Yale Univ, Cheshire, CT; Daniel Friedman, Duke Univ, Durham, NC; Reed Mszar, Georgetown Univ, Manassas, VA; Emily Zeitler, Dartmouth-Hitchcock, Lebanon, NH; Paul Zei, Brigham and Women’s Hosp, Boston, MA; T J Bunch, Univ of Utah Sch of Med, Salt Lake Cty, UT; Moussa Mansour, Massachusetts General Hosp, Boston, MA; Joseph Akar, Jeptha P Curtis, Yale Univ, New Haven, CT; James V Freeman, Yale Univ Sch Med, New Haven, CT

EP.APS.P3. Health Behaviors and Cardiovascular Health Across the Lifecourse
Zone 3, Science and Technology Hall
Mo3038 / 3038 – Comparing Pre- and Post- Pandemic Personal Health Monitoring Using Wearable Devices in United States Adults With or at Risk for Cardiovascular Disease: A Nationally Representative Study
Lovedeep Singh Dhingra, Yale Sch Of Med, New Haven, CT; Arya Aminorroaya, Yale Sch of Med, New Haven, CT; Evangelos K Oikonomou, Yale Sch of Med, New Haven, CT, New Haven, CT; Veer Sangha, Yale Universty, New Haven, CT; Harlan M Krumholz, Yale Univ, New Haven, CT; Rohan Khera, Yale Sch of Med, New Haven, CT

EP.APS.P30. Disparities in Cardiovascular Risk Management, Care, and Access by Social Determinants of Health
Zone 3, Science and Technology Hall
Mo3040 / 3040 – Phenotyping Sub-Populations of Heart Failure Patients Based on Clinical and Social Determinants of Health Using Unsupervised Machine Learning Models
Kateri J Spinelli, Hsin Fang Li, Providence Heart Inst, Portland, OR; deanna Rider, Providence Res Network, Missoula, MT; Jacob Abraham, Providence Heart Inst, Portland, OR; Erica S Spatz, Yale Sch of Med, New Haven, CT; Xiaoyan Huang, Providence Heart Inst, Portland, OR

HF.APS.P38. Game Changing Disease Management in Hypertrophic, Amyloid, and Cardiomyopathy Care
Zone 2, Science and Technology Hall
Mo2197 / 2197 – Evaluation of Impact of Septal Reduction Therapy on Deep Learning-Based Electrocardiographic Markers Hypertrophic Cardiomyopathy
Lovedeep Singh Dhingra, Yale Sch Of Med, New Haven, CT; Arya Aminorroaya, Yale Sch of Med, New Haven, CT; Akshay Khunte, Yale Univ, Colchester, CT; Veer Sangha, Yale Universty, New Haven, CT; Evangelos K Oikonomou, Yale Universty, New Haven, CT, New Haven, CT; Sounok Sen, Yale Universty, New Haven, CT, New Haven, CT, New Haven, CT; Harlan M Krumholz, Yale Univ, New Haven, CT; Christopher M Kramer, Univ. of Virginia Health System, Charlottesville, VA; Milind Y Desai, Univ. of Virginia Health System, Charlottesville, VA, Solon, OH; Rohan Khera, Yale Sch of Med, New Haven, CT

HY.APS.P5. From the Heart to the Brain: Updates in Hypertension Epidemiology
Zone 4, Science and Technology Hall
Mo4124 / 4124 – Leveraging Electronic Health Records to Examine Blood Pressure Patterns Preceding Stroke Events
Dana Lee, Yale Sch of Med, New Haven, CT; Aishwarya Nene, Univ of California San Francisco Sch of Med, San Francisco, CA; Yuntian Liu, Yuan Lu, Erica S Spatz, Yale Sch of Med, New Haven, CT

LF.APS.P5. Physical activity for cardiometabolic disease prevention and management
Zone 3, Science and Technology Hall
Mo3173 / 3173 – Nationally Representative Trends of Overall Physical Activity and Its Subtypes Among US Adults With Diabetes, Hypertension, and Dyslipidemia: Findings From NHANES 2007-2020
Wafa Nabi, Arya Aminorroaya, Yale Sch of Med, New Haven, CT; Lovedeep Singh Dhingra, Yale Sch Of Med, New Haven, CT; Rohan Khera, Yale Sch of Med, New Haven, CT

PH.APS.P10. Shock Talk: Critical Discussions About Cardiogenic Shock Care
Zone 4, Science and Technology Hall
Mo4197 / 4197 – Vasoactive Medication Variability in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock
Christopher Schenck, Soumya Banna, Yale Univ, New Haven, CT; Fouad Chouairi, Duke Univ, Durham, NC; Cory Heck, Yale New Haven Hosp, New Haven, CT; Megan Grammatico, Yale Univ, New Haven, CT; Ajar Kochar, Brigham and Women’s Hosp, Chestnut Hill, MA; Jennifer Miao, Tariq Ali, Yale Univ, New Haven, CT; Jacob C Jentzer, Mayo Clinic, Rochester, MN; Sean Van Diepen, Univ of Alberta, Edmonton, AB, Canada; Elliott Miller, Yale Univ, New Haven, CT

PR.APS.P7. From Artificial Intelligence to Biomarker-based Approaches: Novemberel Strategies for CVD Risk Prognostication and Prevention
Zone 3, Science and Technology Hall
Rohan Khera

QU.APS.P7. Skipping a Beat: Challenges in Cardiovascular Medication Adherence
Zone 3, Science and Technology Hall
Mo3248 / 3248 – Steroidal Mineralocorticoid Receptor Antagonist Treatment Patterns and Predictors of Discontinuation
Emma Richard, Carelon Res, Wilmington, DE; Nihar R Desai, Yale Sch of Med, New Haven, CT; Vincent Willey, Yale Sch of Med, New Haven, CT, Wilmington, DE; Alain Gay, Bayer Schering Pharma France, Loos Cedex, France; Charlie Scott, Kerstin Folkerts, Elena Pessina, Bayer HealthCare Pharmaceuticals, Germany; Chia-Chen Teng, Carelon Res, Wilmington, DE; Nikolaus G. Oberprieler, Bayer HealthCare Pharmaceuticals, Germany

Mo3250 / 3250 – The Adherence and LDL-C Lowering Effect of Inclisiran Among Patients Who Received Treatment at Outpatient Clinics
Nihar R Desai, Yale Sch of Med, New Haven, CT; Nicholas Van Hise, Metro Infusion Ctr, Burr Ridge, IL; Charlene Niu, Novartis Pharmaceuticals, Wellesley, MA; Elizabeth Ghera, Metro Infusion Ctr, Burr Ridge, IL; Sean McElligott, Novartis, Doylestown, PA

VA.APS.P6. Vascular Zebras and Big Data-What to Know and Where to Go
Zone 4, Science and Technology Hall
Mo4294 / 4294 – The Use of Echocardiography in Patients with Advanced Peripheral Arterial Disease
Yasser Jamil, Yale Univ, New Haven, CT; Joshua Huttler, Yale Sch of Med, New Haven, CT; Dana Alameddine, Yale Sch of Med, New Haven, CT, New Haven, CT; Haoran Zhuo, Carlos Mena-Hurtado, Yale Univ, New Haven, CT; Eric J Velazquez, Yale Univ Sch of Med, New Haven, CT; Raul J Guzman, Yale New Haven Hosp, New Haven, CT; Cassius I Ochoa, Yale Sch of Med, New Haven, CT

VA.MDP41. Walking and Talking: Diagnosing and Delivering Proper VTE/PE Therapy
Moderated Digital Posters 1
MDP319 – Double Trouble With Identification of Isolated Sub-Segmental Pulmonary Embolism Using ICD-10 Discharge Diagnosis Codes: The PE-EHR+ Study
Antoine Bejjani, Brigham and Women’s Hosp, Boston, MA; Candrika Dini Khairani, Brigham and Womens Hosp, Boston, MA; Ying-Chih Lo, Brigham and Women’s Hosp, Brookline, MA; David Jimenez, Ramon and Cajal Univ Hosp, Madrid; Stefano Barco, Univ Hosp Zurich, Zurich; Shiwani Mahajan, Yale, New Haven, CT; Cesar Caraballo, Yale Sch of Med, New Haven, CT; Eric A Secemsky, BIDMC, Boston, MA; Erik Klok, Leiden Univ, Leiden; Andetta Hunsaker, Ayaz Aghayev, Brigham and Women’s Hosp, Boston, MA; Alfonso Muriel, Hosp Univrio Ramón Y Cajal, Madrid; Mohamad A Hussain, Abena Appah-Sampong, Brigham and Women’s Hosp, Boston, MA; HAMID MOJIBIAN, Yale Univ Sch of Med, New Haven, NY; Yuan Lu, Yuan Lu, Jersey City, NJ; Zhenqiu Lin, Yale Univ, Cheshire, CT; Sanjay Aneja, Yale Sch Of Med, New Haven, MI; Rohan Khera, Yale Sch of Med, New Haven, CT; Samuel Goldhaber, Brigham and Women’s Hosp, Boston, MA; Li Zhou, Brigham and Women’s Hosp; Manuel Monreal, Hosp Univri Germans Trias i Pujol; Harlan M Krumholz, Yale Univ, New Haven, CT; Gregory Piazza, Brigham and Women’s Hosp, Boston, MA; Behnood Bikdeli, Brigham and Womens Hosp, Boston, MA; PE-EHR+

EP.APS.P5. Predictive Risk Scores and Machine Learning Applications for Cardiovascular Health
Zone 3, Science and Technology Hall
Mo3073 / 3073 – Performance of Current Cardiovascular Risk Scores Among the Brazilian Population: Findings From the ELSA-Brasil Study
Aline Pedroso, Univ Federal de Sao Joao del-Rei, Divinopolis, Brazil; Sandhi Maria Barreto, Univ Federal Minas Gerais, Belo Horizonte, Brazil; Luisa C Brant, Univ Federal de Minas Gerais, Belo Horizonte, Brazil; Antonio Ribeiro, Univ Federal de Minas Gerai, Belo Horizonte, Brazil; Marcio S Bittencourt, UPMC, Pittsburgh, PA; Roberta Figueiredo, UFSJ, Divinopolis, Brazil; Rohan Khera, Yale Sch of Med, New Haven, CT

EP.APS.P9. Global Focus on Cardiovascular Disease Burden
Zone 3, Science and Technology Hall
Mo3113 / 3113 – The Burden of Ischemic Heart Disease in North Africa and Middle East Region From 1990-2019: Results From the GBD Study
Arya Aminorroaya, Yale Sch of Med, New Haven, CT; Sahar Saeedi Moghaddam, Tehran, Iran, Islamic Republic of; Hamed Tavolinejad, Tehran, Iran, Islamic Republic of, Tehran, Iran, Islamic Republic of; Zahra Aryan, Tehran, Iran, Islamic Republic of, Tehran, Iran, Islamic Republic of, Newark, NJ; Behnam Heidari, Tehran, Iran, Islamic Republic of, Tehran, Iran, Islamic Republic of, Newark, NJ, Iran, Islamic Republic of; Hedyeh Ebrahimi, Tehran, Iran, Islamic Republic of, Tehran, Iran, Islamic Republic of, Newark, NJ, Iran, Islamic Republic of, Tehran, Iran, Islamic Republic of; Mohammadreza Naderian, Mayo Clinic, MN; Parnian Shobeiri, Mayo Clinic, MN, Tehran, Iran, Islamic Republic of; Ali Ghanbari, Mayo Clinic, MN, Tehran, Iran, Islamic Republic of, Tehran, Iran, Islamic Republic of; Nazila Rezaei, Mayo Clinic, MN, Tehran, Iran, Islamic Republic of, Tehran, Iran, Islamic Republic of, Tehran, Iran, Islamic Republic of; Mohammad-Reza Malekpour, Mayo Clinic, MN, Tehran, Iran, Islamic Republic of, Tehran, Iran, Islamic Republic of, Tehran, Iran, Islamic Republic of, Tehran, Iran, Islamic Republic of; Rosa Haghshenas, Mayo Clinic, MN, Tehran, Iran, Islamic Republic of, Tehran, Iran, Islamic Republic of, Tehran, Iran, Islamic Republic of, Tehran, Iran, Islamic Republic of, Tehran, Iran, Islamic Republic of; Negar Rezaei, Tehran Univ of Medical Scienc, Tehran, Iran, Islamic Republic of; Bagher Larijani, Tehran Univ of Medical Scienc, Tehran, Iran, Islamic Republic of, Tehran, Iran, Islamic Republic of; Farshad Farzadfar, Tehran Univ of Medical Scienc, Tehran, Iran, Islamic Republic of, Tehran, Iran, Islamic Republic of, Tehran, Iran, Islamic Republic of

EP.MDP47. Large Language Models (ie. ChatGPT) and AI Changing the Way We Assess Risk and Identify patients
Moderated Digital Posters 5
MDP125 – Deep Learning Model for Detection of Conduction Disorders and Arrhythmias From PDF Outputs of Commercially Available Wearable Devices
Veer Sangha, Yale Universty, New Haven, CT; Akshay Khunte, Yale Univ, New Haven, CT; Lovedeep Singh Dhingra, Yale Sch Of Med, New Haven, CT; Evangelos K Oikonomou, Yale Sch Of Med, New Haven, CT, New Haven, CT; Rohan Khera, Yale Sch of Med, New Haven, CT

HF.APS.P44. Highlights in Heart Failure Research
Zone 2, Science and Technology Hall
Mo2279 / 2279 – Selective Serotonin Reuptake Inhibitors Use and Risk of Takotsubo Syndrome in Women
Elena Salmoirago-Blotcher, Brown Medical Sch, Providence, RI; shira dunsiger, Brown Univ Sch of Public Health, RI; Christopher Breault, The Miriam Hosp, Providence, RI; Christopher Song, Brown Medical Sch, RI; Gerard P Aurigemma, UMASS Memorial, Worcester, MA; Matthew Burg, Yale Sch of Med, West Haven, CT

HR.RFO33. The Pharmacologic Management of Heart Failure: Beyond Guidelines and Paradigms
Zone 2, Science and Technology Hall
549 – Effect of Torsemide vs. Furosemide Among Patients With New Onset and Worsening Heart Failure: The Transform-HF Randomized Trial
SELIM R KRIM, Senthil Anand, Ochsner Medical Ctr, New Orleans, LA; Stephen J Greene, Durham, NC; ANQI CHEN, Daniel Wojdyla, Duke Clinical Res Inst, Durham, NC; Juan Vilaro, Univ of Florida, Gainsville, FL; Haught Herbert, Huntsville Hosp, Huntsville, AL; John M Herre, Sentara Norfolk General Hosp, Norfolk, VA; Eric L Eisenstein, Duke Clinical Reseach Inst, Durham, NC; Kevin Anstrom, Univ of North Carolina, Chapel Hill, NC; Bertram Pitt, Univ of Michigan Sch, Ann Arbor, MI; Eric J Velazquez, Yale Univ Sch of Med, New Haven, CT; Robert J Mentz, Duke Clinical Res Inst, Durham, NC

IM.APS.P20. Look to the Recuse!
Zone 2, Science and Technology Hall
Mo2378 / 2378 – Biodistribution, Dosimetry, and Specificity of A99mTc-Labeled Matrix Metalloproteinase Targeted Radiotracer (99mTc-RP805) for Myocardial Infarct Imaging
Stephanie L. Thorn, Yale Univ, New Haven, CT; Lisa A. Freeburg, Francis G Spinale, USC Sch of Med, Columbia, SC; Albert J Sinusas, Yale Univ Sch of Med, New Haven, CT

QU.APS.P9. From Evidence to Excellence: Optimizing Health Services for Cardiovascular Quality
Zone 3, Science and Technology Hall
Mo3272 / 3272 – Use of Ultrasound Enhancing Agents in Echocardiography for Stroke Across Yale New Haven Health System
Gini Priyadharshini Jeyashanmugaraja, Md Mashiul Alam, Yale New Haven Health Bridgeport Hosp, Bridgeport, CT; Robert L McNamara, Evgeny Shkolnik, Yale Sch of Med, New Haven, CT

VA.AOS.557. Emerging PAD Therapies and Insights: Translating Clinical Science for PAD Patients
103B
364 – Predictors of Long-Term Mortality in Chronic Limb Threatening Ischemia Derived From a Random Forest Machine-Learning Model
Santiago Callegari, Gaelle Romain, Yale Univ, New Haven, CT; Jacob Cleman, New Haven, CT; Lindsey Scierka, Jeremy Provance, Carlos Mena-Hurtado, Kim G Smolderen, Yale Univ, New Haven, CT

VA.MDP42. Dissections, Obstructions, and Discovering Ways Forward for Life and Limb Threatening Events
Moderated Digital Posters 1
MDP326 – Short-Term Risk Prognostication for All-Cause Mortality After Endovascular Revascularization in the Medicare Claims-Linked VQI Registry
Jacob Cleman, New Haven, CT; Gaelle Romain, Santiago Callegari, Lindsey Scierka, Francky Jacque, Yale Univ, New Haven, CT; Jeremy B Provance, Yale Sch of Med, New Haven, CT; Kim G Smolderen, Carlos Mena-Hurtado, Yale Univ, New Haven, CT

Leave a Reply

Your email address will not be published. Required fields are marked *